FAR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.251800E-01
Normal-vs-Stage2
9.081800E-01
Normal-vs-Stage3
2.006600E-01
Normal-vs-Stage4
4.811000E-01
Stage1-vs-Stage2
4.971700E-02
Stage1-vs-Stage3
4.040000E-01
Stage1-vs-Stage4
2.483000E-01
Stage2-vs-Stage3
2.099600E-01
Stage2-vs-Stage4
3.996800E-01
Stage3-vs-Stage4
1.384580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.157200E-01
Normal-vs-AfricanAmerican
3.352000E-01
Normal-vs-Asian
6.361600E-01
Caucasian-vs-AfricanAmerican
2.704000E-01
Caucasian-vs-Asian
3.747000E-01
AfricanAmerican-vs-Asian
6.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.998600E-01
Normal-vs-Female
9.807800E-01
Male-vs-Female
6.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.945200E-01
Normal-vs-Age(41-60Yrs)
8.562600E-01
Normal-vs-Age(61-80Yrs)
9.238000E-01
Normal-vs-Age(81-100Yrs)
6.390000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.693400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.311200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.893800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.573800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.483800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.623200E-01
Normal-vs-Daily Drinker
9.614200E-01
Normal-vs-Weekly Drinker
8.720000E-01
Normal-vs-Occasional Drinker
3.380200E-01
Normal-vs-Social Drinker
9.180600E-01
Non Drinker-vs-Daily Drinker
8.421600E-01
Non Drinker-vs-Weekly Drinker
7.853600E-01
Non Drinker-vs-Occasional Drinker
1.092610E-01
Non Drinker-vs-Social Drinker
9.231000E-01
Daily Drinker-vs-Weekly Drinker
6.853600E-01
Daily Drinker-vs-Occasional Drinker
8.133600E-02
Daily Drinker-vs-Social Drinker
7.891600E-01
Weekly Drinker-vs-Occasional Drinker
3.449800E-01
Weekly Drinker-vs-Social Drinker
8.717800E-01
Occasional Drinker-vs-Social Drinker
1.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.006400E-01
Normal-vs-Grade 2
6.472200E-02
Normal-vs-Grade 3
9.500300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.556300E-02
Grade 1-vs-Grade 3
2.570200E-02
Grade 1-vs-Grade 4
2.006400E-01
Grade 2-vs-Grade 3
2.361000E-01
Grade 2-vs-Grade 4
6.472200E-02
Grade 3-vs-Grade 4
9.500300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.883400E-01
Normal-vs-NonDiabetic
9.364400E-01
Diabetic-vs-NonDiabetic
7.728000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.099000E-01
Normal-vs-NoPancreatitis
9.539400E-01
Pancreatitis-vs-NoPancreatitis
5.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.096000E-01
Normal-vs-N1
9.182800E-01
N0-vs-N1
9.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.095200E-01
Normal-vs-TP53-NonMutant
9.738200E-01
TP53-Mutant-vs-TP53-NonMutant
4.063600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
